← ranked final candidates

#11 INCY — INCYTE CORP

B_VCP_DEVELOPING | as of 2026-09-16 | automated relative priority, not a published Minervini point formula

Relative priority59.20
RS rating84.66
Fundamental strength88.00
VCP score84.13
Pivot distance4.63%
AV confirmation—%pending
Technical chart for INCY

Trend Template

price_above_sma150_and_sma200PASS
sma150_above_sma200PASS
sma200_rising_1mPASS
sma50_above_sma150_and_sma200PASS
price_above_sma50PASS
price_at_least_30pct_above_52w_lowPASS
price_within_25pct_of_52w_highPASS
rs_rating_at_least_70PASS

Trend Template metrics

close124.75
sma50121.96
sma150106.59
sma200105.41
sma200_1m_ago102.85
pct_above_52w_low53.84
pct_below_52w_high5.92
rs_rating84.66

VCP conditions

coherent_contraction_sequencePASS
enough_contractionsPASS
successive_ranges_inside_firstPASS
successive_depths_contractingPASS
final_contraction_tightPASS
base_depth_okPASS
resistance_area_tightPASS
volume_dryupFAIL
atr_contractingFAIL
price_tightPASS
near_pivotPASS

VCP metrics

num_contractions2.00
contraction_depths_pct[12.69, 7.03]
depth_ratios_vs_prior[0.554]
target_depth_ratio_roughly_half0.50
max_allowed_depth_ratio0.80
base_high132.60
base_low115.77
base_depth_pct12.69
base_duration_weeks7.10
resistance_spread_pct1.36
volume_dryup_ratio_10d_vs_50d0.90
atr_pct_recent2.63
atr_pct_prior3.08
atr_contraction_ratio0.85
tight_10d_range_pct8.36
raw_contraction_count9.00
raw_depths_pct[4.0, 7.14, 8.65, 6.75, 12.91, 7.07, 4.26, 12.69, 7.03]
final_trough_age_bars11.00
selection_reasoncoherent_current_sequence
pivot_price130.80
distance_to_pivot_pct4.63
vcp_score_pct84.13
is_vcp_candidatePASS
breakout_on_volumeFAIL

Price / volume

return_1m_pct1.01
return_3m_pct25.06
return_6m_pct32.40
return_12m_pct50.05
weighted_12m_momentum13.90
range_10d_pct8.36
range_20d_pct9.03
avg_volume_50d1.57M
dollar_volume_50d195.46M
up_down_volume_ratio_50d1.10
accumulation_days_20d4.00
distribution_days_20d3.00

Fundamental overlay criteria

eps_growth_minimumPASS
sales_growth_positive_or_betterPASS
core_data_coveragePASS
eps_acceleratingFAIL
sales_acceleratingPASS
gross_margin_improvingFAIL
operating_margin_improvingPASS

Minervini-oriented SEC fundamentals

eps_growth_yoy_pct83.75
eps_previous_q_yoy_growth_pct290.74
eps_acceleration_pts-206.99
eps_annual_growth_pct4,173
eps_cagr_3y_pct61.56
sales_growth_yoy_pct20.87
sales_previous_q_yoy_growth_pct20.05
sales_acceleration_pts0.83
sales_annual_growth_pct21.22
sales_cagr_3y_pct14.84
gross_margin_pct91.79
operating_margin_pct23.66
pretax_margin_pct27.00
net_margin_pct23.83
gross_margin_yoy_change_pts-1.26
operating_margin_yoy_change_pts4.17
roe_latest_fy_pct29.87
current_ratio3.68
debt_to_equity_pct—
cash_to_debt—
shares_outstanding—
adjusted_eps_growth_yoy_pct—
earnings_surprise_pct—
eps_estimate_revision_30d_pct—
analyst_count—
institutional_ownership_pct—
institutional_qoq_change_pct—
management_guidance_revision_pct—

SEC data quality

core_coverage_pct90.00
missing_core_metrics["shares_outstanding"]
selected_sec_tags{"accounts_payable": "us-gaap:AccountsPayableCurrent", "accounts_receivable": null, "capex": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "cash": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "cost_of_revenue": "us-gaap:CostOfRevenue", "current_assets": "us-gaap:AssetsCurrent", "current_liabilities": "us-gaap:LiabilitiesCurrent", "dividends_paid": null, "eps_basic": "us-gaap:EarningsPerShareBasic", "eps_diluted": "us-gaap:EarningsPerShareDiluted", "equity": "us-gaap:StockholdersEquity", "gross_profit": null, "inventory": "us-gaap:InventoryNet", "long_term_debt": "us-gaap:LongTermDebtNoncurrent", "long_term_debt_current": "us-gaap:LongTermDebtCurrent", "net_income": "us-gaap:NetIncomeLoss", "operating_cash_flow": "us-gaap:NetCashProvidedByUsedInOperatingActivities", "operating_income": "us-gaap:OperatingIncomeLoss", "pretax_income": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "r_and_d": "us-gaap:ResearchAndDevelopmentExpense", "revenue": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "sga": "us-gaap:SellingGeneralAndAdministrativeExpense", "share_repurchases": "us-gaap:PaymentsForRepurchaseOfCommonStock", "shares_outstanding": "dei:EntityCommonStockSharesOutstanding", "short_term_debt": "us-gaap:DebtCurrent", "short_term_investments": "us-gaap:MarketableSecuritiesCurrent", "stock_based_comp": "us-gaap:ShareBasedCompensation", "total_assets": "us-gaap:Assets", "total_liabilities": "us-gaap:Liabilities", "weighted_avg_diluted_shares": "us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding"}
unavailable_canonical_concepts["accounts_receivable", "dividends_paid", "gross_profit"]
warnings["Standalone Q4 income/EPS can be absent because 10-K statements are annual.", "Company-specific extension tags are not returned by CompanyFacts.", "Non-GAAP EPS, guidance, 13F ownership, Form 4 activity, and analyst estimates are separate modules."]

Reporting periods

latest_quarter_end2026-03-31
latest_quarter_filed2026-04-28
latest_fiscal_year_end2025-12-31
latest_balance_sheet_end2026-03-31

Company metadata

symbolINCY
cik879,169
company_nameINCYTE CORP
exchange—
sic8,731
sic_descriptionServices-Commercial Physical & Biological Research
fiscal_year_end1,231
as_of2026-09-16
sourceSEC EDGAR CompanyFacts + Submissions

Alpha Vantage enrichment

endpoints_returned[]

Alpha Vantage confirmation screen

latest_earnings_surprise_positive—
average_4q_earnings_surprise_positive—
positive_surprise_quarters—
analyst_coverage_present—
eps_revision_breadth_nonnegative_30d—
institutional_sponsorship_present—

Alpha Vantage screen summary

statusinsufficient_data
confirmation_score_pct—
available_criteria0.00
noteInformational post-Exp0 confirmation only; not part of validated Exp0 selection/ranking.

Alpha Vantage endpoint status

EARNINGSpending
EARNINGS_ESTIMATESpending
INSTITUTIONAL_HOLDINGSpending

Accepted VCP contractions

peak_datepeak_pricetrough_datetrough_pricedepth_pctdepth_ratio_vs_priorbars
2026-07-28132.602026-08-06115.7712.69—7.00
2026-08-25130.802026-08-31121.617.030.554.00

Recent SEC filings

formfiling_dateaccession_numberprimary_document
8-K2026-08-310000879169-26-000058incy-20260831.htm
10-Q2026-07-280000879169-26-000056incy-20260630.htm
8-K2026-07-280000879169-26-000053incy-20260728.htm
8-K2026-07-060000879169-26-000048incy-20260706.htm
8-K2026-06-220000879169-26-000046incy-20260622.htm
8-K2026-06-090000879169-26-000043incy-20260608.htm
8-K2026-06-080000879169-26-000040incy-20260608.htm
10-Q2026-04-280000879169-26-000026incy-20260331.htm
8-K2026-04-280000879169-26-000023incy-20260428.htm
8-K2026-03-300000879169-26-000018incy-20260326.htm
8-K2026-03-260000879169-26-000016incy-20260325.htm
8-K2026-03-060000879169-26-000013incy-20260227.htm

SEPA factors not covered by SEC + Yahoo

These remain manual or require another provider/module and are deliberately not guessed: